The Enterprise Value as of December 2025 (TTM) for Cadrenal Therapeutics, Inc. Common Stock (CVKD) is 19.18M

According to Cadrenal Therapeutics, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 19.18M. This represents a change of -3.80% compared to the average of 19.93M of the last 4 quarters.

Cadrenal Therapeutics, Inc. Common Stock (CVKD) Historical Enterprise Value (quarterly & annually)

How has CVKD Enterprise Value performed in the past?

The mean historical Enterprise Value of Cadrenal Therapeutics, Inc. Common Stock over the last ten years is 19.15M. The current 19.18M Enterprise Value has changed 9.91% with respect to the historical average. Over the past ten years (40 quarters), CVKD's Enterprise Value was at its highest in in the September 2022 quarter at 719.44M. The Enterprise Value was at its lowest in in the September 2023 quarter at -226786.00.

Cadrenal Therapeutics, Inc. Common Stock (CVKD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cadrenal Therapeutics, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cadrenal Therapeutics, Inc. Common Stock (CVKD) Average Enterprise Value

How has CVKD Enterprise Value performed in the past?

The current Enterprise Value of Cadrenal Therapeutics, Inc. Common Stock (CVKD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cadrenal Therapeutics, Inc. Common Stock (CVKD) Enterprise Value vs. Peers

How is CVKD’s Enterprise Value compared to its peers?

Cadrenal Therapeutics, Inc. Common Stock’s Enterprise Value is greater than Klotho Neurosciences, Inc. (18.48M), greater than Rallybio Corporation (18.77M), less than Exicure, Inc. (35.58M), greater than TAO Synergies Inc. (8.89M), greater than iBio, Inc. (-4380600.00), greater than Sonnet BioTherapeutics Holdings, Inc. (8.18M), less than CollPlant Biotechnologies Ltd. (21.10M), greater than Iterum Therapeutics plc (10.14M), less than NeurAxis, Inc. (24.74M), less than NeuroSense Therapeutics Ltd. (28.93M),

Build a custom stock screener for Cadrenal Therapeutics, Inc. Common Stock (CVKD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cadrenal Therapeutics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cadrenal Therapeutics, Inc. Common Stock (CVKD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cadrenal Therapeutics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.